Cite
MLA Citation
K. Lorenz et al.. “PB2126: R-CPOP AS FIRST LINE TREATMENT FOR DLBCL PATIENTS WITH SIGNIFICANT REDUCED LVEF OR HIGH RISK OF ANTHRACYCLINE INDUCED CARDIOTOXICITY.” HemaSphere, vol. 6, n.d., pp. 1997–1998. http://access.bl.uk/ark:/81055/vdc_100158013726.0x000025